MERSANA THERAPEUTICS INC. - COMMON STOCK

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 апр 2024 16:30:28 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

28 фев 2024 07:00:08 Источник Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

27 фев 2024 08:01:15 Источник Nasdaq GlobeNewswire

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

21 фев 2024 08:00:22 Источник Nasdaq GlobeNewswire

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference

01 фев 2024 08:00:46 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

05 янв 2024 08:01:19 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 дек 2023 16:30:01 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

07 ноя 2023 07:00:55 Источник Nasdaq GlobeNewswire

Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023

31 окт 2023 16:30:25 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056

31 окт 2023 08:00:01 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Changes in Leadership

06 сен 2023 07:00:40 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Second Quarter 2023 Financial Results

08 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 авг 2023 16:05:52 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization

27 июл 2023 07:06:23 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials

15 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

24 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

09 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 май 2023 16:05:01 Источник Nasdaq GlobeNewswire